Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Cardiovascular Medicine
Metadata
Title
Ebstein malformation of the tricuspid valve: Current concepts in management and outcomes
Authors
Morgan L. Brown
Joseph A. Dearani
Publication date
01-10-2009
Publisher
Current Science Inc.
Published in
Current Treatment Options in Cardiovascular Medicine / Issue 5/2009
Print ISSN: 1092-8464
Electronic ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-009-0041-5

Other articles of this Issue 5/2009

Current Treatment Options in Cardiovascular Medicine 5/2009 Go to the issue

OriginalPaper

New and emerging antiarrhythmic drugs for atrial fibrillation: What may become available to the clinician in the near future

OriginalPaper

Therapeutic implications of automatic home monitoring of implantable cardiac devices

OriginalPaper

Current treatment of aortopulmonary window

OriginalPaper

Pharmaceutical management of decompensated heart failure syndrome in children: Current state of the art and a new approach

OriginalPaper

Role of wearable and automatic external defibrillators in improving survival in patients at risk for sudden cardiac death

OriginalPaper

Management of postoperative pediatric cardiac arrhythmias: Current state of the art

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits